| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.19 | 4e-05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.001 |